JP2022521407A5 - - Google Patents
Info
- Publication number
- JP2022521407A5 JP2022521407A5 JP2021549323A JP2021549323A JP2022521407A5 JP 2022521407 A5 JP2022521407 A5 JP 2022521407A5 JP 2021549323 A JP2021549323 A JP 2021549323A JP 2021549323 A JP2021549323 A JP 2021549323A JP 2022521407 A5 JP2022521407 A5 JP 2022521407A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- cancer
- macc1
- wnt
- niclosamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024212155A JP2025032215A (ja) | 2019-02-22 | 2024-12-05 | Ｗｎｔシグナル伝達及びｍａｃｃ１の阻害剤の医薬配合剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19158805.2 | 2019-02-22 | ||
| EP19158805 | 2019-02-22 | ||
| PCT/EP2020/054641 WO2020169812A1 (en) | 2019-02-22 | 2020-02-21 | Pharmaceutical combination of wnt signaling and macc1 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212155A Division JP2025032215A (ja) | 2019-02-22 | 2024-12-05 | Ｗｎｔシグナル伝達及びｍａｃｃ１の阻害剤の医薬配合剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521407A JP2022521407A (ja) | 2022-04-07 |
| JP2022521407A5 true JP2022521407A5 (https=) | 2023-02-22 |
Family
ID=65529517
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549323A Pending JP2022521407A (ja) | 2019-02-22 | 2020-02-21 | Ｗｎｔシグナル伝達及びｍａｃｃ１の阻害剤の医薬配合剤 |
| JP2024212155A Pending JP2025032215A (ja) | 2019-02-22 | 2024-12-05 | Ｗｎｔシグナル伝達及びｍａｃｃ１の阻害剤の医薬配合剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212155A Pending JP2025032215A (ja) | 2019-02-22 | 2024-12-05 | Ｗｎｔシグナル伝達及びｍａｃｃ１の阻害剤の医薬配合剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220125807A1 (https=) |
| EP (1) | EP3927333A1 (https=) |
| JP (2) | JP2022521407A (https=) |
| CA (1) | CA3128968A1 (https=) |
| WO (1) | WO2020169812A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870204A (zh) * | 2021-01-19 | 2021-06-01 | 南方医科大学 | 物质lf3在调控dclk2蛋白质的表达中的应用 |
| KR20250036293A (ko) * | 2023-09-06 | 2025-03-14 | 재단법인 아산사회복지재단 | Ilk 저해제를 포함하는 말초신경종양 예방 또는 치료용 약학 조성물 및 이의 용도 |
| KR20250036314A (ko) * | 2023-09-06 | 2025-03-14 | 재단법인 아산사회복지재단 | Pdk3 저해제를 포함하는 말초신경종양 예방 또는 치료용 약학 조성물 및 이의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007284801A1 (en) | 2006-08-08 | 2008-02-21 | The Regents Of The University Of Californina | Salicylanilides enhance oral delivery of therapeutic peptides |
| ES2647072T3 (es) * | 2011-04-18 | 2017-12-19 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | Niclosamida para el tratamiento de la metástasis en el cáncer |
| WO2016020427A1 (en) * | 2014-08-05 | 2016-02-11 | Charité - Universitätsmedizin Berlin | Macc1 inhibitors and use thereof in the treatment of cancer |
-
2020
- 2020-02-21 CA CA3128968A patent/CA3128968A1/en active Pending
- 2020-02-21 JP JP2021549323A patent/JP2022521407A/ja active Pending
- 2020-02-21 WO PCT/EP2020/054641 patent/WO2020169812A1/en not_active Ceased
- 2020-02-21 EP EP20705725.8A patent/EP3927333A1/en active Pending
- 2020-02-21 US US17/310,756 patent/US20220125807A1/en active Pending
-
2024
- 2024-12-05 JP JP2024212155A patent/JP2025032215A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2407532C9 (ru) | Комбинации, предназначенные для лечения заболеваний, включающих пролиферацию клеток | |
| ES2307463T3 (es) | Forma de dosificación de combinación que contiene un agente reductor del colesterol, un inhibidor de la renina-angiotensina, y aspirina. | |
| JP2022521407A5 (https=) | ||
| CN104173272B (zh) | 一种异硫氰酸酯类化合物的缓释制剂 | |
| JP2006206613A (ja) | 粘膜炎の処置および予防のための方法および組成物 | |
| US8853188B2 (en) | Compositions and methods for cancer treatment | |
| US10759803B2 (en) | Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto | |
| ZA202501471B (en) | Preparation and use of quinazolinone derivative as kinase inhibitor | |
| JP2017535600A (ja) | メラノーマの処置に使用するためのアピリモド | |
| JP2005506982A5 (https=) | ||
| JP2002518448A (ja) | 高血中コレステロールを治療する組成物および方法 | |
| TW200418485A (en) | Rifalazil compositions and therapeutic regimens | |
| JP4540986B2 (ja) | ワートマニン類似体およびそれらを用いる方法 | |
| JP2002518449A (ja) | 高血中コレステロールを治療する組成物および方法 | |
| CN101795684A (zh) | 他汀类化合物与抗肥胖药的组合 | |
| CA2891300A1 (en) | Inhibition of drug resistant cancer cells | |
| RU2010110658A (ru) | Композиции для лечения неопластических заболеваний | |
| RU2006138035A (ru) | Применение производного фенотиазина для профилактики и/или лечения потери слуха | |
| JP2011518828A5 (https=) | ||
| JP2005525391A5 (https=) | ||
| TW201219037A (en) | Prophylactic and/or therapeutic agent against lymphedema | |
| US6890941B1 (en) | Compositions containing HMG Co-A reductase inhibitors and policosanol | |
| CA2480275A1 (en) | Statin therapy for enhancing cognitive maintenance | |
| JP4892477B2 (ja) | 新規なトリグリセリド低下剤 | |
| ES2647912T3 (es) | Derivados de triazina para uso en un tratamiento de cicatrización |